Ildong Holdings Co Ltd (000230) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Ildong Holdings Co Ltd (000230) has a cash flow conversion efficiency ratio of 0.042x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩14.45 Billion ≈ $9.79 Million USD) by net assets (₩345.58 Billion ≈ $234.19 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See debt-free asset ratio of Ildong Holdings Co Ltd to measure how much of total assets are equity-financed.
Ildong Holdings Co Ltd - Cash Flow Conversion Efficiency Trend (1999–2025)
This chart illustrates how Ildong Holdings Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check 000230 cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.
Ildong Holdings Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Ildong Holdings Co Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Inmax Holding Co Ltd
TWO:1591
|
-0.044x |
|
Precision Optics Corporation, Inc. Common stock
NASDAQ:POCI
|
-0.036x |
|
Laserbond Ltd
AU:LBL
|
0.102x |
|
Sentry Select Primary Metals Corp
TO:PME
|
0.010x |
|
Magnitude International Ltd Ordinary Shares
NASDAQ:MAGH
|
N/A |
|
Havanna Holding SA
BA:HAVA
|
0.080x |
|
Ado Optronics
TWO:3516
|
0.009x |
|
Bokwang Industry Co Ltd
KQ:225530
|
-0.005x |
Annual Cash Flow Conversion Efficiency for Ildong Holdings Co Ltd (1999–2025)
The table below shows the annual cash flow conversion efficiency of Ildong Holdings Co Ltd from 1999 to 2025. For the full company profile with market capitalisation and key ratios, see Ildong Holdings Co Ltd stock valuation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | ₩345.58 Billion ≈ $234.19 Million |
₩26.86 Billion ≈ $18.21 Million |
0.078x | +14.04% |
| 2024-12-31 | ₩254.00 Billion ≈ $172.13 Million |
₩17.31 Billion ≈ $11.73 Million |
0.068x | +120.05% |
| 2023-12-31 | ₩169.90 Billion ≈ $115.14 Million |
₩-57.77 Billion ≈ $-39.15 Million |
-0.340x | +22.91% |
| 2022-12-31 | ₩169.10 Billion ≈ $114.60 Million |
₩-74.59 Billion ≈ $-50.55 Million |
-0.441x | -164.76% |
| 2021-12-31 | ₩183.34 Billion ≈ $124.25 Million |
₩-30.54 Billion ≈ $-20.70 Million |
-0.167x | -717.76% |
| 2020-12-31 | ₩305.61 Billion ≈ $207.11 Million |
₩8.24 Billion ≈ $5.59 Million |
0.027x | -39.62% |
| 2019-12-31 | ₩321.09 Billion ≈ $217.60 Million |
₩14.34 Billion ≈ $9.72 Million |
0.045x | +18.19% |
| 2018-12-31 | ₩164.95 Billion ≈ $111.78 Million |
₩6.23 Billion ≈ $4.22 Million |
0.038x | +401.14% |
| 2017-12-31 | ₩174.64 Billion ≈ $118.35 Million |
₩-2.19 Billion ≈ $-1.49 Million |
-0.013x | -102.87% |
| 2016-12-31 | ₩106.84 Billion ≈ $72.40 Million |
₩46.64 Billion ≈ $31.61 Million |
0.437x | +172.31% |
| 2015-12-31 | ₩349.98 Billion ≈ $237.18 Million |
₩56.11 Billion ≈ $38.03 Million |
0.160x | +35.63% |
| 2014-12-31 | ₩332.95 Billion ≈ $225.64 Million |
₩39.36 Billion ≈ $26.67 Million |
0.118x | +146.72% |
| 2013-12-31 | ₩326.60 Billion ≈ $221.34 Million |
₩15.65 Billion ≈ $10.60 Million |
0.048x | -15.88% |
| 2012-12-31 | ₩324.42 Billion ≈ $219.85 Million |
₩18.48 Billion ≈ $12.52 Million |
0.057x | -65.41% |
| 2011-12-31 | ₩310.17 Billion ≈ $210.20 Million |
₩51.08 Billion ≈ $34.61 Million |
0.165x | +86.76% |
| 2010-12-31 | ₩295.00 Billion ≈ $199.92 Million |
₩26.01 Billion ≈ $17.63 Million |
0.088x | -50.51% |
| 2009-12-31 | ₩280.27 Billion ≈ $189.94 Million |
₩49.93 Billion ≈ $33.84 Million |
0.178x | +114.85% |
| 2007-12-31 | ₩195.76 Billion ≈ $132.66 Million |
₩16.23 Billion ≈ $11.00 Million |
0.083x | -60.80% |
| 2006-12-31 | ₩172.99 Billion ≈ $117.23 Million |
₩36.60 Billion ≈ $24.80 Million |
0.212x | +60.45% |
| 2005-12-31 | ₩146.78 Billion ≈ $99.47 Million |
₩19.35 Billion ≈ $13.12 Million |
0.132x | -32.30% |
| 2004-12-31 | ₩124.97 Billion ≈ $84.69 Million |
₩24.34 Billion ≈ $16.49 Million |
0.195x | +387.25% |
| 2003-12-31 | ₩105.71 Billion ≈ $71.64 Million |
₩4.23 Billion ≈ $2.86 Million |
0.040x | -73.63% |
| 2002-12-31 | ₩94.84 Billion ≈ $64.27 Million |
₩14.37 Billion ≈ $9.74 Million |
0.152x | -49.07% |
| 2001-12-31 | ₩79.37 Billion ≈ $53.79 Million |
₩23.62 Billion ≈ $16.01 Million |
0.298x | +10.87% |
| 2000-12-31 | ₩66.98 Billion ≈ $45.39 Million |
₩17.98 Billion ≈ $12.18 Million |
0.268x | +40.58% |
| 1999-12-31 | ₩55.81 Billion ≈ $37.82 Million |
₩10.66 Billion ≈ $7.22 Million |
0.191x | -- |
About Ildong Holdings Co Ltd
Ildong Holdings Co., Ltd. develops, manufactures, and supplies pharmaceutical products in South Korea and internationally. It develops new drugs against resistant bacteria, malignant tumors, Alzheimer's disease, obesity, and ageing; and raw vitamins, probiotics, and antimicrobials, as well as offers Biovita, a lactobacillus product; and Aronamin, a multivitamin product. It is also involved in the… Read more